SCHEMBL5852158

SCHEMBL5852158

CN(C)C(=O)Oc1ccc(C[C@H](NC(=O)C2(N(C)S(=O)(=O)Cc3ccccc3)CCCC2)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 19/20 0.52
ITGA4 P13612 19/20 0.52
ITGB7 P26010 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850545 0.83 ITGB1 (0.52) ITGB1ITGA4ITGB7
SCHEMBL5850981 0.80 ITGB1 (0.48) ITGB1ITGA4
SCHEMBL5850641 0.76 ITGB1 (0.44) ITGB1ITGA4ITGB7
SCHEMBL5850857 0.75 ITGB1 (0.64) ITGB1ITGA4ITGB7
SCHEMBL5850823 0.74 ITGB1 (0.42) ITGB1ITGA4ITGB7
SCHEMBL5852330 0.74 ACHE (0.42) ITGB1ITGA4
SCHEMBL7401948 0.73 ITGB1 (0.61) ITGB1ITGA4ITGB7
SCHEMBL5850329 0.72 ITGB1 (0.41) ITGB1ITGA4ITGB7
SCHEMBL5862642 0.72 KMT2A (0.57) ITGB1ITGA4
SCHEMBL6568912 0.72 ITGB1 (0.51) ITGB1ITGA4ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP disclosed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed